The global Coccidia Virus Live Vaccine market  size is set to grow from  US$ 99 million in 2025 to US$ 135 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.

Global Coccidia Virus Live Vaccine Market Growth and Outlook 2025-31

The global Coccidia Virus Live Vaccine market size is predicted to grow from US$ 99 million in 2025 to US$ 135 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031. The coccidia virus live vaccine is a vaccine used to prevent coccidiosis in poultry, such as chickens. Coccidiosis, caused by Eimeria spp., is a parasitic infection that primarily affects the intestines of poultry, leading to diarrhea, weight loss, and even death. This vaccine uses attenuated live coccidia viruses to simulate an infection, stimulating the immune system to produce antibodies and enhancing the poultrys immunity against future coccidia infections. Compared to traditional coccidiostat treatments, the vaccine not only helps reduce the development of drug resistance but also improves poultry production performance, such as weight gain in broilers and egg production in layers, promoting a more sustainable and environmentally friendly poultry industry. United States market for Coccidia Virus Live Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Coccidia Virus Live Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Coccidia Virus Live Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Coccidia Virus Live Vaccine players cover MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Coccidia Virus Live Vaccine Industry Forecast looks at past sales and reviews total world Coccidia Virus Live Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Coccidia Virus Live Vaccine sales for 2025 through 2031. With Coccidia Virus Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coccidia Virus Live Vaccine industry. This Insight Report provides a comprehensive analysis of the global Coccidia Virus Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coccidia Virus Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Coccidia Virus Live Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coccidia Virus Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coccidia Virus Live Vaccine. This report presents a comprehensive overview, market shares, and growth opportunities of Coccidia Virus Live Vaccine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Bivalent Vaccine &nbsp;&nbsp;&nbsp; Trivalent Vaccine &nbsp;&nbsp;&nbsp; Quadrivalent Vaccine Segmentation by Application: &nbsp;&nbsp;&nbsp; Poultry &nbsp;&nbsp;&nbsp; Rabbit &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; MSD Animal Health &nbsp;&nbsp;&nbsp; Boehringer Ingelheim &nbsp;&nbsp;&nbsp; HIPRA &nbsp;&nbsp;&nbsp; Bioproperties &nbsp;&nbsp;&nbsp; Huvepharma &nbsp;&nbsp;&nbsp; Nisseiken &nbsp;&nbsp;&nbsp; Biopharm &nbsp;&nbsp;&nbsp; Ceva Sant Animale &nbsp;&nbsp;&nbsp; Vaxxinova &nbsp;&nbsp;&nbsp; Foshan Standard Biotech &nbsp;&nbsp;&nbsp; Qilu Qingda Bio-Pharmaceutical &nbsp;&nbsp;&nbsp; Skystar Bio-pharm Key Questions Addressed in this Report What is the 10-year outlook for the global Coccidia Virus Live Vaccine market? What factors are driving Coccidia Virus Live Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Coccidia Virus Live Vaccine market opportunities vary by end market size? How does Coccidia Virus Live Vaccine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Coccidia Virus Live Vaccine Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Coccidia Virus Live Vaccine by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Coccidia Virus Live Vaccine by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Coccidia Virus Live Vaccine Segment by Type &nbsp;2.2.1 Bivalent Vaccine &nbsp;2.2.2 Trivalent Vaccine &nbsp;2.2.3 Quadrivalent Vaccine &nbsp;2.3 Coccidia Virus Live Vaccine Sales by Type &nbsp;2.3.1 Global Coccidia Virus Live Vaccine Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Coccidia Virus Live Vaccine Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Coccidia Virus Live Vaccine Sale Price by Type (2020-2025) &nbsp;2.4 Coccidia Virus Live Vaccine Segment by Application &nbsp;2.4.1 Poultry &nbsp;2.4.2 Rabbit &nbsp;2.4.3 Other &nbsp;2.5 Coccidia Virus Live Vaccine Sales by Application &nbsp;2.5.1 Global Coccidia Virus Live Vaccine Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Coccidia Virus Live Vaccine Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Coccidia Virus Live Vaccine Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Coccidia Virus Live Vaccine Breakdown Data by Company &nbsp;3.1.1 Global Coccidia Virus Live Vaccine Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Coccidia Virus Live Vaccine Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Coccidia Virus Live Vaccine Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Coccidia Virus Live Vaccine Revenue by Company (2020-2025) &nbsp;3.2.2 Global Coccidia Virus Live Vaccine Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Coccidia Virus Live Vaccine Sale Price by Company &nbsp;3.4 Key Manufacturers Coccidia Virus Live Vaccine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Coccidia Virus Live Vaccine Product Location Distribution &nbsp;3.4.2 Players Coccidia Virus Live Vaccine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Coccidia Virus Live Vaccine by Geographic Region &nbsp;4.1 World Historic Coccidia Virus Live Vaccine Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Coccidia Virus Live Vaccine Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Coccidia Virus Live Vaccine Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Coccidia Virus Live Vaccine Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Coccidia Virus Live Vaccine Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Coccidia Virus Live Vaccine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Coccidia Virus Live Vaccine Sales Growth &nbsp;4.4 APAC Coccidia Virus Live Vaccine Sales Growth &nbsp;4.5 Europe Coccidia Virus Live Vaccine Sales Growth &nbsp;4.6 Middle East & Africa Coccidia Virus Live Vaccine Sales Growth 5 Americas &nbsp;5.1 Americas Coccidia Virus Live Vaccine Sales by Country &nbsp;5.1.1 Americas Coccidia Virus Live Vaccine Sales by Country (2020-2025) &nbsp;5.1.2 Americas Coccidia Virus Live Vaccine Revenue by Country (2020-2025) &nbsp;5.2 Americas Coccidia Virus Live Vaccine Sales by Type (2020-2025) &nbsp;5.3 Americas Coccidia Virus Live Vaccine Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Coccidia Virus Live Vaccine Sales by Region &nbsp;6.1.1 APAC Coccidia Virus Live Vaccine Sales by Region (2020-2025) &nbsp;6.1.2 APAC Coccidia Virus Live Vaccine Revenue by Region (2020-2025) &nbsp;6.2 APAC Coccidia Virus Live Vaccine Sales by Type (2020-2025) &nbsp;6.3 APAC Coccidia Virus Live Vaccine Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Coccidia Virus Live Vaccine by Country &nbsp;7.1.1 Europe Coccidia Virus Live Vaccine Sales by Country (2020-2025) &nbsp;7.1.2 Europe Coccidia Virus Live Vaccine Revenue by Country (2020-2025) &nbsp;7.2 Europe Coccidia Virus Live Vaccine Sales by Type (2020-2025) &nbsp;7.3 Europe Coccidia Virus Live Vaccine Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Coccidia Virus Live Vaccine by Country &nbsp;8.1.1 Middle East & Africa Coccidia Virus Live Vaccine Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Coccidia Virus Live Vaccine Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Coccidia Virus Live Vaccine Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Coccidia Virus Live Vaccine Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Coccidia Virus Live Vaccine &nbsp;10.3 Manufacturing Process Analysis of Coccidia Virus Live Vaccine &nbsp;10.4 Industry Chain Structure of Coccidia Virus Live Vaccine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Coccidia Virus Live Vaccine Distributors &nbsp;11.3 Coccidia Virus Live Vaccine Customer 12 World Forecast Review for Coccidia Virus Live Vaccine by Geographic Region &nbsp;12.1 Global Coccidia Virus Live Vaccine Market Size Forecast by Region &nbsp;12.1.1 Global Coccidia Virus Live Vaccine Forecast by Region (2026-2031) &nbsp;12.1.2 Global Coccidia Virus Live Vaccine Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Coccidia Virus Live Vaccine Forecast by Type (2026-2031) &nbsp;12.7 Global Coccidia Virus Live Vaccine Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 MSD Animal Health &nbsp;13.1.1 MSD Animal Health Company Information &nbsp;13.1.2 MSD Animal Health Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.1.3 MSD Animal Health Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 MSD Animal Health Main Business Overview &nbsp;13.1.5 MSD Animal Health Latest Developments &nbsp;13.2 Boehringer Ingelheim &nbsp;13.2.1 Boehringer Ingelheim Company Information &nbsp;13.2.2 Boehringer Ingelheim Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.2.3 Boehringer Ingelheim Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Boehringer Ingelheim Main Business Overview &nbsp;13.2.5 Boehringer Ingelheim Latest Developments &nbsp;13.3 HIPRA &nbsp;13.3.1 HIPRA Company Information &nbsp;13.3.2 HIPRA Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.3.3 HIPRA Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 HIPRA Main Business Overview &nbsp;13.3.5 HIPRA Latest Developments &nbsp;13.4 Bioproperties &nbsp;13.4.1 Bioproperties Company Information &nbsp;13.4.2 Bioproperties Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.4.3 Bioproperties Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Bioproperties Main Business Overview &nbsp;13.4.5 Bioproperties Latest Developments &nbsp;13.5 Huvepharma &nbsp;13.5.1 Huvepharma Company Information &nbsp;13.5.2 Huvepharma Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.5.3 Huvepharma Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Huvepharma Main Business Overview &nbsp;13.5.5 Huvepharma Latest Developments &nbsp;13.6 Nisseiken &nbsp;13.6.1 Nisseiken Company Information &nbsp;13.6.2 Nisseiken Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.6.3 Nisseiken Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Nisseiken Main Business Overview &nbsp;13.6.5 Nisseiken Latest Developments &nbsp;13.7 Biopharm &nbsp;13.7.1 Biopharm Company Information &nbsp;13.7.2 Biopharm Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.7.3 Biopharm Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Biopharm Main Business Overview &nbsp;13.7.5 Biopharm Latest Developments &nbsp;13.8 Ceva Sant� Animale &nbsp;13.8.1 Ceva Sant� Animale Company Information &nbsp;13.8.2 Ceva Sant� Animale Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.8.3 Ceva Sant� Animale Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Ceva Sant� Animale Main Business Overview &nbsp;13.8.5 Ceva Sant� Animale Latest Developments &nbsp;13.9 Vaxxinova &nbsp;13.9.1 Vaxxinova Company Information &nbsp;13.9.2 Vaxxinova Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.9.3 Vaxxinova Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Vaxxinova Main Business Overview &nbsp;13.9.5 Vaxxinova Latest Developments &nbsp;13.10 Foshan Standard Biotech &nbsp;13.10.1 Foshan Standard Biotech Company Information &nbsp;13.10.2 Foshan Standard Biotech Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.10.3 Foshan Standard Biotech Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Foshan Standard Biotech Main Business Overview &nbsp;13.10.5 Foshan Standard Biotech Latest Developments &nbsp;13.11 Qilu Qingda Bio-Pharmaceutical &nbsp;13.11.1 Qilu Qingda Bio-Pharmaceutical Company Information &nbsp;13.11.2 Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.11.3 Qilu Qingda Bio-Pharmaceutical Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Qilu Qingda Bio-Pharmaceutical Main Business Overview &nbsp;13.11.5 Qilu Qingda Bio-Pharmaceutical Latest Developments &nbsp;13.12 Skystar Bio-pharm &nbsp;13.12.1 Skystar Bio-pharm Company Information &nbsp;13.12.2 Skystar Bio-pharm Coccidia Virus Live Vaccine Product Portfolios and Specifications &nbsp;13.12.3 Skystar Bio-pharm Coccidia Virus Live Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Skystar Bio-pharm Main Business Overview &nbsp;13.12.5 Skystar Bio-pharm Latest Developments 14 Research Findings and Conclusion

Report	Global Coccidia Virus Live Vaccine Market Growth 2025-2031
Selected License	Multi ID: LPI16340

Buyer Information

Order Summary